Decio, Alessandra <br/><br/>
Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin.  [electronic resource] 

 -  Clinical & experimental metastasis  Oct 2015 
 - 647-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7276 
<br/><br/><label>Standard No.: </label>10.1007/s10585-015-9734-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cisplatin--pharmacology<br/>Female<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Ovarian Neoplasms--pathology<br/>Paclitaxel--pharmacology<br/>Quinazolines--pharmacology<br/>Xenograft Model Antitumor Assays